TY - JOUR
T1 - Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease
AU - Serebruany, Victor L.
AU - O'Connor, Christopher M.
AU - Gurbel, Paul A.
PY - 2001/6/15
Y1 - 2001/6/15
N2 - The inhibitory effects of SSRIs on platelet function observed in our study may be directly related to the association between treatment of depression and improved outcomes in patients with coronary artery disease. In recognizing antiplatelet properties of SSRIs, their combination with thienopyridines and glycoprotein IIb/IIIa inhibitors should be considered with caution. Future strategies must consider safe approaches to protect platelets from extensive activation, and for these purposes SSRIs may represent an optimal class of dual agents treating depression and simultaneously inhibiting platelets.
AB - The inhibitory effects of SSRIs on platelet function observed in our study may be directly related to the association between treatment of depression and improved outcomes in patients with coronary artery disease. In recognizing antiplatelet properties of SSRIs, their combination with thienopyridines and glycoprotein IIb/IIIa inhibitors should be considered with caution. Future strategies must consider safe approaches to protect platelets from extensive activation, and for these purposes SSRIs may represent an optimal class of dual agents treating depression and simultaneously inhibiting platelets.
UR - http://www.scopus.com/inward/record.url?scp=0035877011&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035877011&partnerID=8YFLogxK
U2 - 10.1016/S0002-9149(01)01562-4
DO - 10.1016/S0002-9149(01)01562-4
M3 - Article
C2 - 11397363
AN - SCOPUS:0035877011
SN - 0002-9149
VL - 87
SP - 1398
EP - 1400
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 12
ER -